Mon - Fri 09:00-18:00 0207 060 3773
Email info@boundarycapital.com

By

admin

Pure Potions continues with success with products now being stocked in Boots

November 14, 2016
Portfolio company Pure Potions continue to go from strength to strength with products now being stocked in leading retailers Boots, QVC, Waitrose and Holland & Barrett. Pure Potions make products formulated especially for use by those prone to dry skin. Their creams, ointments and oils are made from the very finest ingredients – many of...
Read More

Dymag launches new BOXSTROMTM carbon hybrid auto wheel

November 14, 2016
Boundary investee Dymag has launched its new BOXSTROMTM carbon hybrid auto wheel aimed at OEMs and the aftermarket in early November. The wheel is typically 40% lighter than standard cast wheels and 25% lighter than forged wheels yet fully meets the relevant testing standards. To achieve this Dymag developed several patent-pending innovations for the new...
Read More

Boundary partners with Yati Capital to open investment opportunities from India

November 14, 2016
Boundary has partnered with advisers Yati Capital, to create investment streams from India and provide geographic reach to portfolio companies. Boundary has already secured additional investment as a result of the new partnership into their AngelPlus Fund, from Indian entrepreneur Rajneesh Bhandari. Rajneesh Bhandari is a first generation serial entrepreneur and has promoted four successful ventures in Telecommunication,...
Read More

Boundary partnering the Kuber Aristotle EIS/SEIS Roadshow 9 – 12 January 2017

November 14, 2016
Boundary Capital is delighted to be partnering the Kuber Aristotle EIS/SEIS Roadshow. A world of diversification in one place. The Kuber Aristotle Roadshow clearly exemplifies “the whole is greater than the sum of its parts” with 9 managers on the road showcasing a collective strength and depth covering a multitude of different industries and sectors...
Read More

Boundary to host debate at the WiseAlpha VCT & EIS Investor Forum 2016

November 7, 2016
Come and join Karren Brady, 100s of private investors, dozens of fund managers and around 450 other delegates at The WiseAlpha VCT & EIS Investor Forum 2016, 24th November, Bishopsgate, London. Boundary Capital will be leading a special debate on the day called: Some Like it Hot! Where can you make the best returns by...
Read More

Boundary Capital invests in Disruptive Sports IoT Technology

October 20, 2016
Boundary Capital has announced its latest investment in Precision Sports Technology, a business which has the potential to disrupt the professional and amateur sports markets. Precision Sports Technology has developed innovative hardware and software which can be used in live competition by athletes to predict injury and fatigue. It does this by taking life signs...
Read More

Case study: Desktop Genetics

June 29, 2016
Gene editing is one of hottest areas of life sciences. Many scientists are working towards using CRISPR technology to provide genetic solutions to conditions by literally editing the DNA in the genes. Desktop Genetics provides gene editing software (SaaS and on-prem) to make CRISPR gene editing easy and cost-effective. With their platform, DESKGEN, scientists can...
Read More

Boundary Capital invests in Disruptive Antimicrobial Technology

May 12, 2016
Boundary Capital has announced its latest investment in Toxibact, a disruptive technology which has the potential to kill a wide range of microorganisms including bacteria and fungi with little prospect of them being able to develop resistance. Toxibact has a novel potential antimicrobial therapy for the treatment of all bacteria – both ‘gram positive’ and...
Read More

Boundary Capital invests in Ground-breaking Alzheimer’s Therapeutic Technology

April 28, 2016
Boundary Capital has announced its latest investment in AB-Polyblok, a revolutionary technology which has the potential to treat, and potentially partially reverse, the effects of Alzheimer’s Disease. AB-Polyblock has a novel potential drug therapy for the treatment of Alzheimer’s Disease. The drug was conceived and developed after independent, private research. Alzheimer’s Disease is the largest...
Read More

Boundary Capital in the Press: EIS Magazine

April 13, 2016
Boundary Capital is featured in this month’s issue of EIS Magazine discussing the pros and cons of Crowdfunding… Crowdfunding: Where Angels Fear to Tread? Dan Somers, Managing Partner at London-based Boundary Capital Partners, says that crowdfunding is a phenomenon of our age: “Whilst most crowdfunding is debt-based, UK equity crowdfunding (our focus here) rose from...
Read More
1 … 3 4 5 6 7

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases